Vaccines, blood, antisera, toxins and cultures in   Guinea

Exports In 2022, Guinea exported $8.85k in Vaccines, blood, antisera, toxins and cultures, making it the 163rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 209th most exported product in Guinea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Guinea are: France ($8.83k) and Austria ($20).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Guinea between 2021 and 2022 were France ($4.81k) and Austria ($20).

Imports In 2022, Guinea imported $35.8M in Vaccines, blood, antisera, toxins and cultures, becoming the 136th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 39th most imported product in Guinea. Guinea imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($14.3M), Belgium ($10.7M), China ($6.02M), India ($2.85M), and South Korea ($559k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Guinea between 2021 and 2022 were United States ($4.84M), Belgium ($3.88M), and United Kingdom ($236k).